Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Wigen Biomedicine Technology presents GTPase KRAS mutant inhibitors

July 21, 2021

Tecnimede-Sociedade Tecnico-Medicinal discloses compounds for tuberculosis

July 21, 2021

Medshine Discovery patents new compounds for NASH

July 21, 2021

SRI International describes lipoxygenase inhibitors

July 20, 2021

Angex Pharmaceutical synthesizes new mTOR inhibitors

July 20, 2021

Sitryx Therapeutics presents new NFE2L2 activators

July 20, 2021

Sumitomo Dainippon Pharma divulges 5-HT2A and/or 5-HT7 receptor antagonists

July 20, 2021

UCB discloses new FCER1A mutant inhibitors

July 19, 2021

Wigen Biomedicine Technology presents KRAS mutant inhibitors

July 19, 2021

TYK Medicines divulges new Ret inhibitors

July 19, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
ASH 2025: Ianalumab data offer break from chronic ITP therapy
BioWorld
Novartis AG’s monoclonal antibody, ianalumab (VAY-736), when added to standard-of-care eltrombopag, extended disease control of primary immune thrombocytopenia...